SQUAMOUS CELL CARCINOMA
Clinical trials for SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cancer drug trial halted after early testing
Disease control TerminatedThis early-stage study tested a new drug called OC-001, both by itself and combined with an existing immunotherapy drug, in people with various advanced cancers that had stopped responding to standard treatments. The main goal was to check the safety of the drug and see how the b…
Matched conditions: SQUAMOUS CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Ocellaris Pharma, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
Early trial halted: testing a powerful combo for tough head & neck cancers
Disease control TerminatedThis early-stage study aimed to find a safe dose for combining a new immunotherapy drug (pembrolizumab) with standard chemotherapy and radiation for patients with advanced head and neck cancer. It focused on measuring side effects, especially in the mouth and skin, to see if the …
Matched conditions: SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: Royal Marsden NHS Foundation Trust • Aim: Disease control
Last updated Mar 02, 2026 15:26 UTC
-
Scientists hunt for lung Cancer's genetic fingerprint
Knowledge-focused TerminatedThis study aimed to find genetic markers that could predict how quickly squamous cell lung cancer might worsen. Researchers collected small tissue and blood samples from patients who had or were having lung procedures. The goal was to analyze the DNA from these samples to identif…
Matched conditions: SQUAMOUS CELL CARCINOMA
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:42 UTC